3D-QSAR and molecular modeling of HIV-1 integrase inhibitors
暂无分享,去创建一个
[1] V. Kulkarni,et al. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study. , 1999, Journal of medicinal chemistry.
[2] S. Goff,et al. Genetics of retroviral integration. , 1992, Annual review of genetics.
[3] D. A. Dougherty,et al. The Cationminus signpi Interaction. , 1997, Chemical reviews.
[4] Vithal M. Kulkarni,et al. Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations , 2000, J. Comput. Aided Mol. Des..
[5] M. Orozco,et al. Molecular-mechanics modelling of drug-DNA structures; the effects of differing dielectric treatment on helix parameters and comparison with a fully solvated structural model. , 1990, Journal of biomolecular structure & dynamics.
[6] Douglas D. Richman,et al. HIV chemotherapy : AIDS , 2001 .
[7] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[8] A. Engelman,et al. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication , 1995, Journal of virology.
[9] M Le Bret,et al. Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives. , 2000, Journal of medicinal chemistry.
[10] Y. Pommier,et al. Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors , 1997, Antimicrobial agents and chemotherapy.
[11] Beat Ernst,et al. Drug discovery today. , 2003, Current topics in medicinal chemistry.
[12] Y. Pommier,et al. Thiazolothiazepine inhibitors of HIV-1 integrase. , 1999, Journal of medicinal chemistry.
[13] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[14] S. Ueda,et al. Integration is essential for efficient gene expression of human immunodeficiency virus type 1 , 1993, Journal of virology.
[15] M C Nicklaus,et al. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. , 1997, Journal of medicinal chemistry.
[16] Gerhard Klebe,et al. Comparative Molecular Similarity Indices Analysis: CoMSIA , 1998 .
[17] T. Burke,et al. Cell protein cross-linking by erbstatin and related compounds. , 1996, Biochemical Pharmacology.
[18] D. E. Patterson,et al. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .
[19] V. Kulkarni,et al. Comparative molecular field analysis of fungal squalene epoxidase inhibitors. , 1999, Journal of medicinal chemistry.
[20] Erik De Clercq,et al. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. , 1995 .
[21] M. Levitt,et al. Refinement of protein conformations using a macromolecular energy minimization procedure. , 1969, Journal of molecular biology.
[22] G Klebe,et al. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. , 1999, Journal of medicinal chemistry.
[23] T R Burke,et al. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. , 1998, Journal of medicinal chemistry.
[24] M C Nicklaus,et al. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. , 1997, Journal of medicinal chemistry.
[25] Y. Pommier,et al. Coumarin-based inhibitors of HIV integrase. , 1997, Journal of medicinal chemistry.
[26] W. Schleif,et al. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells , 1992, Journal of virology.
[27] J N Weinstein,et al. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study. , 1995, Journal of medicinal chemistry.
[28] W. Haseltine,et al. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration , 1994, Journal of virology.
[29] Tudor I. Oprea,et al. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules. , 1993, Journal of medicinal chemistry.
[30] A Tropsha,et al. Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. , 1995, Journal of medicinal chemistry.